News
The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...
Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.
These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...
The global cell culture market is projected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by increasing ...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...
Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...
Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo, eye drug Vabysmo and allergy treatment Xolair.
Pharma stocks rally on Trump's tariff pause, led by up to 7% surge in Laurus Labs, Granules, Cipla Apr 11 2025 05:21 PM Stocks to Watch Today: TCS, Biocon, GAIL, Greaves Cotton, Sun Pharma ...
Thank you, Operator, and welcome, everyone, to the Nanalysis Scientific’s fourth quarter and full year 2024 conference call.
Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...
AI and automation are revolutionizing biopharmaceutical manufacturing by enhancing efficiency, improving quality control and ...
19h
Medical Device Network on MSNIntuitive warns of escalating tariff impact through 2025, despite strong Q1CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results